iCellate
iCellate is a Swedish research and development company focused on cancer research and detection products.
Total raised
€4.6M
€4,600,000
Funding rounds
2
Investors
0
distinct backers
Active since
2019-09
latest 2021-02
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 15y since founding
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-02-10 | Other | €2.4M | — | View deal → |
| 2019-10-01 | Series D+ | €2.2M | — | View deal → |